Kyongbo Pharmaceutical Co., Ltd (KRX:214390)

Kyongbo Pharmaceutical Revenue

Kyongbo Pharmaceutical had revenue of 66.13B KRW in the quarter ending March 31, 2026, with 9.14% growth. This brings the company's revenue in the last twelve months to 269.64B, up 13.99% year-over-year. In the year 2025, Kyongbo Pharmaceutical had annual revenue of 264.10B with 10.71% growth.

• Revenue (ttm): 269.64B
• Revenue Growth: +13.99%
• P/S Ratio: 0.49
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 131.73B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	264.10B	25.55B	10.71%
Dec 31, 2024	238.56B	22.20B	10.26%
Dec 31, 2023	216.36B	20.09B	10.24%
Dec 31, 2022	196.26B	25.61B	15.00%
Dec 31, 2021	170.66B	-44.63B	-20.73%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 2, 2026

Data Sources Report a data error